Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Mirabegron in Overactive Bladder (CAPRICORN)
NCT00912964Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Apr 2009; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00912964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912964.